Instrumento Inactivo

Otros idiomas Insys Therapeutics Inc Nasdaq

Acciones

US45824V2097

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Special Fraud Alert: Speaker Programs – If It's Too Good To Be True, It Probably Is	27/11/20
INSYS Therapeutics, Inc.'s Equity Buyback announced on November 5, 2015, has expired.	31/03/20
INSYS Therapeutics, Inc. Went Out of Business	18/02/20
INSYS THERAPEUTICS, INC. : Other Events (form 8-K)	11/02/20
INSYS THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	10/02/20
Bankruptcy Judge Changed for INSYS Therapeutics, Inc.	06/02/20
INSYS THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	05/02/20
Second Motion for Exclusivity Period Extension Approved For INSYS Therapeutics, Inc.	22/01/20
INSYS THERAPEUTICS, INC. : Regulation FD Disclosure (form 8-K)	17/01/20
Modified Second Amended Liquidation Plan Approved for INSYS Therapeutics, Inc.	16/01/20
INSYS Therapeutics : Ex-pharma exec sentenced to nearly 3 years in bribery scheme	14/01/20
INSYS Therapeutics : Ex-drug company execs face reckoning in opioid bribery case	12/01/20
INSYS THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	10/01/20
INSYS THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	06/01/20
INSYS THERAPEUTICS, INC. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	26/12/19
Renaissance Lakewood, LLC completed the acquisition of certain assets of INSYS Therapeutics, Inc. (OTCPK:INSY.Q).	19/12/19
Motion for Asset Sale Approved for INSYS Therapeutics, Inc.	16/12/19
Second Amended Disclosure Statement Approved for INSYS Therapeutics, Inc.	04/12/19
INSYS THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Changes in Registrant's Certifying Accountant, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	03/12/19
Renaissance Lakewood, LLC entered into an asset purchase agreement to acquire certain assets of INSYS Therapeutics, Inc. (OTCPK:INSY.Q) for $0.28 million.	03/12/19

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Insys Therapeutics Inc Nasdaq

Acciones

US45824V2097

Otros idiomas

Filtros